Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Motus Gi Holdings Inc (MOTS)

Motus Gi Holdings Inc (MOTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Motus GI Announces 1-FOR-20 Reverse Stock Split

FORT LAUDERDALE, Fla., July 25, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Motus GI to Release Second Quarter Results and Provide a Business Update on August 11

FORT LAUDERDALE, Fla., July 21, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System in Hard-to-Prepare Patients Presented at Digestive Disease Week 2022

– The Pure-Vu system improved the adequate cleansing rate more than 200% to 97.7% in patients with a history of poor bowel preparation FORT LAUDERDALE,...

MOTS : 0.0001 (unch)
Motus GI Reports First Quarter 2022 Financial Results and Provides Business Update

Pure-Vu EVS approved for use at 11 hospitals since product launch commenced in March 2022; with strong procedural volumes and significant positive feedback...

MOTS : 0.0001 (unch)
Motus GI to Release First Quarter Results and Provide a Business Update on May 12

FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology...

MOTS : 0.0001 (unch)
Sidoti December Micro Cap Virtual Conference

Presentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule...

VMAR : 1.4200 (-3.40%)
HIRE.VN : 0.005 (unch)
LVO : 5.06 (+5.20%)
MOTS : 0.0001 (unch)
MTRX : 12.27 (+0.25%)
CVGI : 4.30 (+4.12%)
FRSX : 2.33 (-2.31%)
HCTI : 2.48 (+0.40%)
PETS : 2.32 (-2.11%)
NSFDF : 0.3095 (+9.79%)
AMST : 1.3500 (-23.30%)
WLMS : 0.3572 (-3.17%)
Sidoti Microcap Virtual Conference

A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti...

VMAR : 1.4200 (-3.40%)
HIRE.VN : 0.005 (unch)
LVO : 5.06 (+5.20%)
MOTS : 0.0001 (unch)
CVGI : 4.30 (+4.12%)
FRSX : 2.33 (-2.31%)
MDWT : 26.99 (unch)
GMBL : 0.1824 (-4.50%)
HCTI : 2.48 (+0.40%)
PETS : 2.32 (-2.11%)
AMST : 1.3500 (-23.30%)
WLMS : 0.3572 (-3.17%)

Barchart Exclusives

Jazz Pharmaceuticals Stock, a Barchart Favorite, Trends Higher as Trump Renews Cannabis Hopes. Should You Buy JAZZ Here?
Jazz Pharmaceuticals stock pops as President Trump signals renewed urgency to reclassify cannabis as Schedule III drug. Technicals signal further upside ahead in JAZZ shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.